RECRUITING

A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning (USF)

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Increased computational power has made it possible to implement complex image recognition tasks and machine learning to be implemented in every day usage. The computer vision and machine learning based solution used in this project (Nelli) is an automatic seizure detection and reporting method that has a CE mark for this specific use. The present study will provide data to expand the utility and detection capability of NELLI and enhance the accuracy and clinical utility of automated computer vision and machine learning based seizure detection.

Official Title

A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning (USF)

Quick Facts

Study Start:2024-11-15
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06705439

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All patients undergoing video-EEG monitoring for clinical purposes who are suspected of having seizures.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

US Agent
CONTACT
+1 (210) 708-0667
contact@neuroeventlabs.com

Principal Investigator

Selim Benbadis, MD
PRINCIPAL_INVESTIGATOR
University of South Florida

Study Locations (Sites)

Tampa General Hospital
Tampa, Florida, 33606
United States

Collaborators and Investigators

Sponsor: Neuro Event Labs Inc.

  • Selim Benbadis, MD, PRINCIPAL_INVESTIGATOR, University of South Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-15
Study Completion Date2025-06

Study Record Updates

Study Start Date2024-11-15
Study Completion Date2025-06

Terms related to this study

Keywords Provided by Researchers

  • Nelli

Additional Relevant MeSH Terms

  • Epilepsy